Letter to Shareholders

CORONA, CA--(Marketwired - December 01, 2015) - Acology Inc. (OTC PINK: ACOL) announced today that the calendar year-end will exceed its previously announced sales numbers for its signature product, The MedTainer™. Management declares that the company has progressed in 2015 to the point where more sales associates will be hired to meet the growing demand for the product. It is also projected that by April of 2016 the number of MedTainers distributed within a 30-day cycle will exceeded 75,000 and continue to grow exponentially by mid-summer to 100,000. Projected sales at the end of calendar 2015, previously projected conservatively at $1.3M are now expected to surpass $1.5M in gross sales while at the same time reducing costs and increasing margins.

At the beginning of September 2015 Acology found itself in the unique position of having a single, stand-alone product serving two distinct markets. Acology sales executives had begun to open the geritriac, hospice and palliative care industries and have added 3 distinguished professionals in that field to its Advisory Board. These included 2 of the most well-known executives in the administration of Hospitals, Skilled Nursing Facilities and transitional home-care and one of the premiere geriatricians in the United States. In concert they have introduced Acology to the rapidly-growing medical equipment and skilled-nursing fields and Acology products are now in clinical trials within these industries.

Acology approaches the close of calendar 2015 with the certain knowledge that demand for their signature product, The MedTainer, will continue to increase domestically and globally. It has successfully defended intellectual property incursions into its business space and challenged counterfeit products. The original 45 distributors that Acology held in October of 2014 has grown to over 900 domestic and international distributors, wholesalers, merchants and brokers. The original physical 5200 sq.ft. sales and distribution center in Corona is expanding an additional 5,000 sq. ft. by the beginning of 2016. New business, in the areas already described but especially in the medical industry, will continue to develop and grow exponentially as demand for the Medtainer increases.

Safe Harbor Statement

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's email is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649).